Spatial distribution of taurine metabolic genes (SLC27A5, CAV1) revealed pronounced heterogeneity, with tumor core regions exhibiting hyperactivation of taurine metabolism (Figures 3B, C). This evidence concerns the gene SLC27A5 and neoplasm.